DNA and Gene Sequencing - Clinical Research Informer

Ring 20: Could the rare disease get left behind by next-generation gene sequencing?

pharmaphorum

NOVEMBER 3, 2020

Ring Chromosome 20 Syndrome, or (R)20, is an ultra-rare form of epilepsy with a devastating impact – yet despite huge leaps forward in gene sequencing in recent years, diagnoses are going down instead of up. The post Ring 20: Could the rare disease get left behind by next-generation gene sequencing? appeared first on.

Gene Sequencing

Gene Sequencing Gene Genome Genomics

New CRISPR-Based Tool Called PASTE Gene Editing Inserts Large DNA Sequences at Desired Sites

XTalks

DECEMBER 14, 2022

Developed by MIT researchers Jonathan Gootenberg and Omar Abudayyeh, PASTE (Programmable Addition via Site-specific Targeting Elements) gene editing technology can insert genes as long as 36,000 DNA base pairs to liver cells in mice as well as several types of human cells.

Gene Editing

Gene Editing DNA Gene Gene Sequencing

Hopkins-led research team takes gene mutation detection in blood to the next level

Scienmag

MAY 4, 2021

Credit: Elizabeth Cooke Next-generation gene sequencing (NGS) technologies –in which millions of DNA molecules are simultaneously but individually analyzed– theoretically provides researchers and clinicians the ability to noninvasively identify mutations in the blood stream.

Gene Sequencing

Gene Sequencing Gene Research DNA

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

Takeda grows in gene therapies again with $2bn Code Bio deal

pharmaphorum

FEBRUARY 23, 2022

Interest in non-viral methods of delivering gene therapies has been growing in the face of current scrutiny of the safety of viral vectors like adeno-associated viruses (AAV), with a number of clinical programmes based on AAV under clinical holds imposed by the FDA.

Gene Therapy

Gene Therapy Gene Gene Sequencing Immune Response

#news #biotech Research team develops software that cuts time, cost from gene sequencing

BioTech 365

DECEMBER 3, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Research team develops software that cuts time, cost from gene sequencing.A team of Johns Hopkins University researchers has developed a new software that could revolutionize how DNA … Continue reading →

Gene Sequencing

Gene Sequencing Gene Development Research

Gene therapy specialist bluebird exits “untenable” European market

pharmaphorum

AUGUST 10, 2021

The decision was taken by the UUS regulator after a case of a rare blood cancer (myelodysplastic syndrome) was seen in a patient treated with Skysona that probably arose as a result of the lentiviral vector used to deliver the gene therapy.

Gene Therapy

Gene Therapy Gene Marketing Genetic Disease

Next Generation Sequencing (NGS) Library Preparation Kits Market: Current Scenario and Future Potential

Roots Analysis

FEBRUARY 21, 2022

Since the introduction of a gene sequencing method by Frederick Sanger in 1977, the field of genomic data collection and analysis has evolved significantly. Advancement in DNA sequencing technologies have resulted in noteworthy developments in various healthcare-related research fields, such as diagnostics and personalized medicine.

Marketing

Marketing Gene Sequencing DNA Genome

UK cancer mutation testing firm Biofidelity raises $12m

pharmaphorum

AUGUST 21, 2020

Cambridge, UK-based Biofidelity has raised $12 million in first-round funding for its cancer diagnosis platform, which can detect mutations quicker than current approaches like gene sequencing. Both previously worked at Cambridge-based DNA sequencing specialist Base4 Innovation, where the technology was developed.

DNA

DNA Gene Sequencing Genetics FDA Approval

Next Generation Sequencing (NGS) Library Preparation Kits: Revolutionizing the Field of Genetic Sciences

Roots Analysis

FEBRUARY 23, 2022

Further, NGS library preparation kits offer several benefits, such as low requirement of starting material, generation of longer RNA / DNA sequences and production of superior quality nucleotide libraries, thereby, catering to existing unmet needs of the research domain. Next Generation Sequencing (NGS) Library Preparation Kits.

Genetics

Genetics DNA RNA Reagent

Zynteglo halt re-ignites viral vector safety concerns; analysts

pharmaphorum

FEBRUARY 22, 2021

That therapy uses an adeno-associated virus (AAV) as a vector rather than a lentivirus, a vector type that features in approved gene therapies such as Roche’s Luxturna and Novartis’ Zolgensma. million in Europe.

Gene Therapy

Gene Therapy Gene Gene Sequencing Gene Expression

Touchlight boosts DNA manufacturing capacity with latest expansion

Pharmaceutical Technology

MAY 26, 2023

Enzymatic DNA production company Touchlight have augmented its DNA production capabilities with a newly announced expansion to its London facilities. Tripling its production capacity, Touchlight can now manufacture 8kg plasmid DNA, a key component for mRNA gene therapies and vaccines.

DNA

DNA Manufacturing Gene Gene Therapy

Rising Demand for DNA and Gene Cloning Service Providers

Roots Analysis

OCTOBER 16, 2023

DNA cloning refers to the process of generating multiple copies of a particular DNA segment. DNA and Gene Cloning involves the isolation of a DNA sequence of any species ( often a gene ) and its insertion into a vector to enable growth without any alteration in the original DNA sequence.

DNA

DNA Gene Protein In-Vitro

Oxford Nanopore makes stellar debut on UK stock market

pharmaphorum

OCTOBER 1, 2021

Shares in DNA sequencing specialist Oxford Nanopore rocketed after the company made its debut on the London Stock Exchange yesterday, rising nearly 50% to propel its valuation up towards the £5 billion ($6.7 billion) mark.

Marketing

Marketing Genome Genomics Business Development

Boost for mRNA as Moderna to acquire OriCiro for $85 million

pharmaphorum

JANUARY 5, 2023

The company develops mRNA therapeutics and vaccines , and the move will enable it to utilise the synthetic biology and enzyme tech of 2018-founded Japanese company OriCiro, which develops cell-free DNA synthesis and amplification technologies, and thereby expand Moderna’s portfolio.

Gene Sequencing

Gene Sequencing DNA Vaccination Vaccine

A Reversal on Sequencing? Proposed Legislation Would Allow Patenting of Naturally Occurring Genes

FDA Law Blog

OCTOBER 24, 2024

Rather, developers of diagnostic tests and, indeed of any product that relies on free access to gene sequence and other biomarker information, should pay also close attention, as PERA would overturn longstanding judicial precedent. animal, viral, bacterial) DNA and RNA sequences. Supporters of AMP v.

Gene

Gene DNA Genetics Gene Sequencing

Clinical Research Informer

Ring 20: Could the rare disease get left behind by next-generation gene sequencing?

New CRISPR-Based Tool Called PASTE Gene Editing Inserts Large DNA Sequences at Desired Sites

Webinars

Trending Sources

Hopkins-led research team takes gene mutation detection in blood to the next level

Webinars

Takeda grows in gene therapies again with $2bn Code Bio deal

#news #biotech Research team develops software that cuts time, cost from gene sequencing

Gene therapy specialist bluebird exits “untenable” European market

Next Generation Sequencing (NGS) Library Preparation Kits Market: Current Scenario and Future Potential

UK cancer mutation testing firm Biofidelity raises $12m

Next Generation Sequencing (NGS) Library Preparation Kits: Revolutionizing the Field of Genetic Sciences

Zynteglo halt re-ignites viral vector safety concerns; analysts

Touchlight boosts DNA manufacturing capacity with latest expansion

Rising Demand for DNA and Gene Cloning Service Providers

Oxford Nanopore makes stellar debut on UK stock market

Boost for mRNA as Moderna to acquire OriCiro for $85 million

A Reversal on Sequencing? Proposed Legislation Would Allow Patenting of Naturally Occurring Genes

Stay Connected